Constitutive Formation of Oligomeric Complexes between Family B G Protein-Coupled Vasoactive Intestinal Polypeptide and Secretin Receptors
暂无分享,去创建一个
Laurence J Miller | Patrick M Sexton | P. Sexton | L. Miller | M. Morfis | K. Harikumar | Kaleeckal G Harikumar | Maria M Morfis | Cayle S Lisenbee | Cayle S. Lisenbee
[1] P. Fossier,et al. Monitoring of Ligand-independent Dimerization and Ligand-induced Conformational Changes of Melatonin Receptors in Living Cells by Bioluminescence Resonance Energy Transfer* 210 , 2002, The Journal of Biological Chemistry.
[2] Roland Baron,et al. The Alternatively Spliced Δe13 Transcript of the Rabbit Calcitonin Receptor Dimerizes with the C1a Isoform and Inhibits Its Surface Expression* , 2003, Journal of Biological Chemistry.
[3] P. Sexton,et al. Receptor activity modifying proteins. , 2001, Cellular signalling.
[4] S. Rees,et al. Monitoring Receptor Oligomerization Using Time-resolved Fluorescence Resonance Energy Transfer and Bioluminescence Resonance Energy Transfer , 2001, The Journal of Biological Chemistry.
[5] U. Kumar,et al. Receptors for dopamine and somatostatin: formation of hetero-oligomers with enhanced functional activity. , 2000, Science.
[6] B. Mouillac,et al. Oxytocin and vasopressin V1a and V2 receptors form constitutive homo- and heterodimers during biosynthesis. , 2003, Molecular endocrinology.
[7] B. O'dowd,et al. Oligomerization of mu- and delta-opioid receptors. Generation of novel functional properties. , 2000, The Journal of biological chemistry.
[8] J. Gardner,et al. Cyclic AMP in pancreatic acinar cells: effects of gastrointestinal hormones. , 1976, Gastroenterology.
[9] L. Miller,et al. Molecular pharmacology of the secretin receptor. , 2002, Receptors & channels.
[10] M. Bouvier,et al. Hetero-oligomerization between β2- and β3-Adrenergic Receptors Generates a β-Adrenergic Signaling Unit with Distinct Functional Properties* , 2004, Journal of Biological Chemistry.
[11] G. Milligan,et al. Multiple Interactions between Transmembrane Helices Generate the Oligomeric α1b-Adrenoceptor , 2004, Molecular Pharmacology.
[12] Michel Bouvier,et al. Oligomerization of G-protein-coupled transmitter receptors , 2001, Nature Reviews Neuroscience.
[13] K. Marx,et al. Extracellular cysteines of the corticotropin-releasing factor receptor are critical for ligand interaction. , 1997, Biochemistry.
[14] S. Angers,et al. Detection of beta 2-adrenergic receptor dimerization in living cells using bioluminescence resonance energy transfer (BRET). , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[15] Graeme Milligan,et al. G Protein-Coupled Receptor Dimerization: Function and Ligand Pharmacology , 2004, Molecular Pharmacology.
[16] Jean-François Mercier,et al. Quantitative Assessment of β1- and β2-Adrenergic Receptor Homo- and Heterodimerization by Bioluminescence Resonance Energy Transfer* , 2002, The Journal of Biological Chemistry.
[17] S. Wank,et al. The Extracellular Domain of Receptor Activity-modifying Protein 1 Is Sufficient for Calcitonin Receptor-like Receptor Function* , 2003, The Journal of Biological Chemistry.
[18] A. Hanyaloglu,et al. Constitutive and Agonist-dependent Homo-oligomerization of the Thyrotropin-releasing Hormone Receptor , 2001, The Journal of Biological Chemistry.
[19] L. Miller,et al. Heterodimerization of Type A and B Cholecystokinin Receptors Enhance Signaling and Promote Cell Growth* , 2003, Journal of Biological Chemistry.
[20] L. Ittner,et al. The N-terminal extracellular domain 23-60 of the calcitonin receptor-like receptor in chimeras with the parathyroid hormone receptor mediates association with receptor activity-modifying protein 1. , 2005, Biochemistry.
[21] L. Devi,et al. Oligomerization of opioid receptors. , 2002, Methods.
[22] K. Fuxe,et al. Homodimerization of adenosine A2A receptors: qualitative and quantitative assessment by fluorescence and bioluminescence energy transfer , 2003, Journal of neurochemistry.
[23] Melanie G. Lee,et al. RAMPs regulate the transport and ligand specificity of the calcitonin-receptor-like receptor , 1998, Nature.
[24] Krzysztof Palczewski,et al. Oligomerization of G protein-coupled receptors: past, present, and future. , 2004, Biochemistry.
[25] K. Blumer,et al. Oligomerization, Biogenesis, and Signaling Is Promoted by a Glycophorin A-like Dimerization Motif in Transmembrane Domain 1 of a Yeast G Protein-coupled Receptor* , 2003, Journal of Biological Chemistry.
[26] L. Miller,et al. Paired Cysteine Mutagenesis to Establish the Pattern of Disulfide Bonds in the Functional Intact Secretin Receptor* , 2005, Journal of Biological Chemistry.
[27] A. Engel,et al. Atomic-force microscopy: Rhodopsin dimers in native disc membranes , 2003, Nature.
[28] E. Hollande,et al. Presence of VIP receptors in a human pancreatic adenocarcinoma cell line. Modulation of the cAMP response during cell proliferation. , 1983, Biochemical and biophysical research communications.
[29] R. Latif,et al. Ligand-dependent Inhibition of Oligomerization at the Human Thyrotropin Receptor* , 2002, The Journal of Biological Chemistry.
[30] T. Lybrand,et al. Spatial Approximation between the Amino Terminus of a Peptide Agonist and the Top of the Sixth Transmembrane Segment of the Secretin Receptor* , 2004, Journal of Biological Chemistry.
[31] A. Couvineau,et al. VPAC receptors for VIP and PACAP. , 2002, Receptors & channels.
[32] L. Devi,et al. Dimerization of the delta opioid receptor: implication for a role in receptor internalization. , 1997, The Journal of biological chemistry.
[33] L. Miller,et al. Agonist-dependent Dissociation of Oligomeric Complexes of G Protein-coupled Cholecystokinin Receptors Demonstrated in Living Cells Using Bioluminescence Resonance Energy Transfer* , 2001, The Journal of Biological Chemistry.
[34] Y. Kaziro,et al. Molecular cloning and expression of a cDNA encoding the secretin receptor. , 1991, The EMBO journal.
[35] P. Sexton,et al. Novel Receptor Partners and Function of Receptor Activity-modifying Proteins* , 2003, The Journal of Biological Chemistry.
[36] T. O'donohue,et al. Use of 125I-secretin to identify and characterize high-affinity secretin receptors on pancreatic acini. , 1983, The American journal of physiology.
[37] L. Miller,et al. Silencing of secretin receptor function by dimerization with a misspliced variant secretin receptor in ductal pancreatic adenocarcinoma. , 2002, Cancer research.
[38] A. Estival,et al. Adenocarcinoma of the human exocrine pancreas: presence of secretin and caerulein receptors. , 1981, Biochemical and biophysical research communications.
[39] Graeme Milligan,et al. Dimers of Class A G Protein-coupled Receptors Function via Agonist-mediated Trans-activation of Associated G Proteins* , 2003, Journal of Biological Chemistry.
[40] Patrick M Sexton,et al. The receptor activity modifying protein family of G protein coupled receptor accessory proteins. , 2004, Seminars in cell & developmental biology.
[41] P. Sexton,et al. GPCR modulation by RAMPs. , 2006, Pharmacology & therapeutics.
[42] K. Eidne,et al. Monitoring the formation of dynamic G-protein-coupled receptor-protein complexes in living cells. , 2005, The Biochemical journal.